Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Inhibikase Therapeutics Reports Dosing Of First Patient For Phase 1b Trial Of IkT-148009 For Parkinson's


Benzinga | Oct 19, 2021 08:07AM EDT

Inhibikase Therapeutics Reports Dosing Of First Patient For Phase 1b Trial Of IkT-148009 For Parkinson's






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC